BMYMP - Bristol-Myers Squibb Company (BMY) Presents at Guggenheim Securities Radiopharmaceuticals Day (Transcript)
2024-05-13 14:23:08 ET
Bristol-Myers Squibb Company. (BMY)
Guggenheim Securities Radiopharmaceuticals Day
May 13, 2024, 11:00 AM ET
Company Participants
Ben Hickey - President RayzeBio, Head of Mirati
Conference Call Participants
Presentation
Unidentified Analyst
Alright, Ben, let's continue here with Ben Hickey now from Bristol. Welcome. Thanks for joining us today. And so, yes, before we start with the fireside chat here, yes could you just introduce yourself and talk a bit about your role at Bristol. First of all, good to see you.
Ben Hickey
No, no, we're on. Good morning. Thanks, Michael [ph] for hosting. Yes, Ben Hickey. I'm currently the President of RayzeBio. We are going to run RayzeBio as a Independent Company within the Bristol Myers family. So that'll be a first for Bristol. Prior to that, I was the Chief Commercial Officer and Head of Business Development at Mirati, which was also bought by Bristol-Myers Squibb. And then prior to that, a short stint at Halozyme. And before that, I was actually 17 years at Bristol-Myers. So I'm a bit of a boomerang. So good to be back with Bristol....
Bristol-Myers Squibb Company (BMY) Presents at Guggenheim Securities Radiopharmaceuticals Day (Transcript)